Literature DB >> 10677526

Polycystin 1 is required for the structural integrity of blood vessels.

K Kim1, I Drummond, O Ibraghimov-Beskrovnaya, K Klinger, M A Arnaout.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD), often caused by mutations in the PKD1 gene, is associated with life-threatening vascular abnormalities that are commonly attributed to the frequent occurrence of hypertension. A previously reported targeted mutation of the mouse homologue of PKD1 was not associated with vascular fragility, leading to the suggestion that the vascular lesion may be of a secondary nature. Here we demonstrate a primary role of PKD1 mutations in vascular fragility. Mouse embryos homozygous for the mutant allele (Pkd1(L)) exhibit s.c. edema, vascular leaks, and rupture of blood vessels, culminating in embryonic lethality at embryonic day 15.5. Kidney and pancreatic ductal cysts are present. The Pkd1-encoded protein, mouse polycystin 1, was detected in normal endothelium and the surrounding vascular smooth muscle cells. These data reveal a requisite role for polycystin 1 in maintaining the structural integrity of the vasculature as well as epithelium and suggest that the nature of the PKD1 mutation contributes to the phenotypic variance in ADPKD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677526      PMCID: PMC26504          DOI: 10.1073/pnas.040550097

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families.

Authors:  O Z DALGAARD
Journal:  Acta Med Scand Suppl       Date:  1957

2.  Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein.

Authors:  O Ibraghimov-Beskrovnaya; W R Dackowski; L Foggensteiner; N Coleman; S Thiru; L R Petry; T C Burn; T D Connors; T Van Raay; J Bradley; F Qian; L F Onuchic; T J Watnick; K Piontek; R M Hakim; G M Landes; G G Germino; R Sandford; K W Klinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  Immunolocalization of polycystin in human tissues and cultured cells.

Authors:  M D Griffin; V E Torres; J P Grande; R Kumar
Journal:  Proc Assoc Am Physicians       Date:  1996-05

Review 4.  Epithelial cell polarity and disease.

Authors:  P D Wilson
Journal:  Am J Physiol       Date:  1997-04

Review 5.  Polycystic kidney disease: hereditary and acquired.

Authors:  J J Grantham
Journal:  Adv Intern Med       Date:  1993

6.  Vascular expression of polycystin.

Authors:  M D Griffin; V E Torres; J P Grande; R Kumar
Journal:  J Am Soc Nephrol       Date:  1997-04       Impact factor: 10.121

7.  Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1.

Authors:  R Palsson; C P Sharma; K Kim; M McLaughlin; D Brown; M A Arnaout
Journal:  Mol Med       Date:  1996-11       Impact factor: 6.354

8.  A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier.

Authors:  V Wong; B M Gumbiner
Journal:  J Cell Biol       Date:  1997-01-27       Impact factor: 10.539

9.  Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice.

Authors:  P Soriano
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

10.  Embryonic vascular development: immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos.

Authors:  J D Coffin; T J Poole
Journal:  Development       Date:  1988-04       Impact factor: 6.868

View more
  95 in total

Review 1.  Polycystic kidney disease: In danger of being X-rated?

Authors:  J J Grantham; J P Calvet
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

3.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

Review 4.  Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP.

Authors:  D J Beech; K Muraki; R Flemming
Journal:  J Physiol       Date:  2004-07-22       Impact factor: 5.182

Review 5.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

6.  The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation.

Authors:  Steve Mangos; Pui-ying Lam; Angela Zhao; Yan Liu; Sudha Mudumana; Aleksandr Vasilyev; Aiping Liu; Iain A Drummond
Journal:  Dis Model Mech       Date:  2010-03-24       Impact factor: 5.758

7.  Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia.

Authors:  B Kumar; K Dreja; S S Shah; A Cheong; S-Z Xu; P Sukumar; J Naylor; A Forte; M Cipollaro; D McHugh; P A Kingston; A M Heagerty; C M Munsch; A Bergdahl; A Hultgårdh-Nilsson; M F Gomez; K E Porter; P Hellstrand; D J Beech
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

8.  Inactivation of Pkd1 in principal cells causes a more severe cystic kidney disease than in intercalated cells.

Authors:  Kalani L Raphael; Kevin A Strait; Peter K Stricklett; R Lance Miller; Raoul D Nelson; Klaus B Piontek; Gregory G Germino; Donald E Kohan
Journal:  Kidney Int       Date:  2009-01-14       Impact factor: 10.612

9.  Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes.

Authors:  Almira Kurbegovic; Olivier Côté; Martin Couillard; Christopher J Ward; Peter C Harris; Marie Trudel
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

10.  A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.

Authors:  Samuel C Mok; Tomas Bonome; Vinod Vathipadiekal; Aaron Bell; Michael E Johnson; Kwong-kwok Wong; Dong-Choon Park; Ke Hao; Daniel K P Yip; Howard Donninger; Laurent Ozbun; Goli Samimi; John Brady; Mike Randonovich; Cindy A Pise-Masison; J Carl Barrett; Wing H Wong; William R Welch; Ross S Berkowitz; Michael J Birrer
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.